Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF LOSSES (unaudited)

v3.7.0.1
CONDENSED STATEMENTS OF LOSSES (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses:        
Research and development $ 500 $ 323 $ 965 $ 646
General and administrative 321 384 781 1,091
Total operating expenses 821 707 1,746 1,737
Loss from operations (821) (707) (1,746) (1,737)
Other income (expense):        
Gain on change in fair value of derivative liability 315 217 1,998 755
Interest income (expense), net (45) (1,462) 2
Loss before provision for income taxes (551) (490) (1,210) (980)
Provision for income taxes
Net loss $ (551) $ (490) $ (1,210) $ (980)
Net loss per common share, basic and diluted (in dollars per share) $ (0.35) $ (0.35) $ (0.79) $ (0.70)
Weighted average shares outstanding (in shares) 1,589,890 1,392,079 1,527,536 1,392,079